Merck KGaA, Darmstadt, Germany
Frankfurter Straße 250
Darmstadt
64293
Germany
Tel: 49-6151-720
Fax: 49-6151-722000
Website: https://www.emdgroup.com/en
Email: service@emdgroup.com
650 articles about Merck KGaA, Darmstadt, Germany
-
EMD Serono, Inc. Named as a Top Employer by Science Magazine - Ranked Number 7 out of top 20 Employers Across Life Sciences Industry -
10/9/2008
-
Genentech, Inc. (JOBS) Says Raptiva Patient Develops Brain Disorder
10/3/2008
-
Merck KGaA Open to Taking Part in ImClone Systems Incorporated Bid
9/30/2008
-
Merck KGaA Starts New Phase III Trial on MS Pill
9/18/2008
-
ImClone Systems Incorporated's Erbitux Shows Good, Non-significant Survival Trend
9/16/2008
-
ImClone Systems Incorporated and Bristol-Myers Squibb Company Erbitux Extends Head, Neck Cancer Survival in Study Conducted by Merck KGaA in Germany
9/11/2008
-
Extra Funds For Disease Research From Five Top Pharmas; Money Will Secure 50 Jobs In Dundee Over The Next Four Years -- AstraZeneca PLC, Boehringer Ingelheim GmbH, GlaxoSmithKline, Merck KGaA and Pfizer Inc.
8/6/2008
-
OncoMethylome Sciences S.A. Announces Licensing and Testing Agreement with Merck KGaA
6/10/2008
-
Merck KGaA Buys Rights to Market 30 Bristol-Myers Squibb Company Drugs in Latin America
6/10/2008
-
Mylan Inc. Acquires Central Eastern European Generics Businesses of Merck KGaA
6/2/2008
-
Merck KGaA's Erbitux Gets EU Backing for Wider Use
6/2/2008
-
Merck KGaA Cancer Drug Erbitux Seen Limited Threat To Roche Holding AG and Genentech, Inc. Avastin
6/2/2008
-
Merck KGaA and Caprotec Bioanalytics Sign Collaboration Agreement
5/28/2008
-
BIOTECON Diagnostics and Merck KGaA Start Worldwide Marketing Alliance
4/18/2008
-
German Merck KGaA Says No Reason to Change Outlook
3/28/2008
-
Biolex Therapeutics Enters Into Agreement With Merck KGaA for Antibody Optimization
2/19/2008
-
Merck KGaA, Takeda Pharmaceutical Co. Ltd. Cancel Development of Cancer Drug
2/18/2008
-
Idera Pharmaceuticals, Inc. Announces Clearance for Collaboration Agreement with Merck KGaA
2/6/2008
-
Merck KGaA Signs Licensing Agreement with Sol-Gel
2/4/2008
-
Idera Pharmaceuticals, Inc. and Merck KGaA Forge $400 Million Cancer Drug Deal
12/19/2007